Navigation Links
Mega Events in September, Including Chicago Event This Sat./Sun., Allow Heart Health Campaign to Reach Tens of Thousands of Hispanics During Cholesterol Awareness Month
Date:9/12/2007

nce for Hispanic Health and author of SALUD -- A Latina's Guide to Total Health. "We have an urgent message, one that has already reached millions of Hispanics through our work this summer and we are committed to doing even more to deliver screening and education as part of Cholesterol Awareness Month."

Important Timing for This Campaign

Cholesterol Awareness Month, which coincides with Hispanic Heritage Month (September 15 - October 15) was designated by the National Institutes of Health's National Heart, Lung, and Blood Institute and provides news media with a unique opportunity to share information about hearth health, including the importance of cholesterol screenings.

The Alliance effort is part of the Alliance's Para un corazon saludable (translation: For a healthy heart), a new educational initiative funded by an educational grant from AstraZeneca aimed at improving awareness and understanding of heart disease risk factors, including high cholesterol, among Hispanics.

As part of the screening and educational campaign, Alliance organizations have been jointly conducting a major four-city survey on health issues to gauge additional community challenges. The results of the survey will be released in November at a meeting of leaders in Hispanic cardiology in Orlando, Florida.

"The more we can understand the health challenges Hispanic communities face the better equipped our doctors and other professionals in the health care system will be to provide appropriate care and advice to our patients," said Jack Lewin, M.D., CEO of the American College of Cardiology.

Contacting the Alliance

Given our community's high use of mobile technologies, the Alliance's Heart Health Campaign is also reaching Hispanic families through an innovative two-part campaign that will publicize both a new text message campaign (send the message "CORAZON" or "HEART" to the text message number 30644) and the 1-866-SU-FAMILIA Family Health Helpline.


'/>"/>
SOURCE National Alliance for Hispanic Health
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Breast Feeding prevents obesity later on in life
2. Regular exercise prevents hip fractures
3. Protein Complex prevents cancer
4. Gel prevents pregnancy
5. Staying mentally energitic prevents Alzheimers
6. Consuming fish prevents dementia risk
7. Cardiac events better treated with intense cholesterol-lowering regime
8. Tea Prevents Skin Cancer
9. Research unearths how caffeine prevents us from sleeping
10. Use Of Sunscreen In Childhood And Prevents Future Skin Cancer
11. Handwashing prevents diarrhea and acute lower respiratory infections
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:CAP Deeming Status Renewed 2Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 2Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 3Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 4Health News:Leveraging Cloud Computing is the Latest Offering by ICG Consulting to Streamline Costs While Delivering Robust Business Process Solutions 2Health News:Leveraging Cloud Computing is the Latest Offering by ICG Consulting to Streamline Costs While Delivering Robust Business Process Solutions 3Health News:Mexican health care program successful at reducing crippling health care costs 2Health News:Mexican health care program successful at reducing crippling health care costs 3Health News:Exercise is safe, improves quality of life in patients with chronic heart failure 2Health News:Exercise is safe, improves quality of life in patients with chronic heart failure 3Health News:New Prostate Cancer Drug May Hold Promise 2Health News:New Prostate Cancer Drug May Hold Promise 3
Breaking Medicine Technology:Pharmacy Technician Employment Increasing Up to 32% By 2016 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 1EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 2EcoActive Surfaces Introduces OxiTitan VLR 3A New Light Powered Antimicrobial Coating Effective Against Viruses and Bacteria Indoors 55480 3Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 1Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 2Lakewood Amedex Inc to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains 4904 3New Fastrack Technology Improves Productivity 55477 1New Fastrack Technology Improves Productivity 55477 2New Fastrack Technology Improves Productivity 55477 3
Other Medicine Technology:Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 2Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 3Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 4Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 5Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 6Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 7Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 8Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 9Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region 2Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region 3Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region 4